Upload
others
View
10
Download
0
Embed Size (px)
Citation preview
Copyright © 2019 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States and various other countries.
M02 2019
Facts from IQVIA
1
Indicator RUB USD EUR PACKS
Value M02/YTD'19, Bln. 179 2,7 2,4 0,8
Growth M02/YTD'19% 20% 2,5% 10% 3,7%
Market grew by 20% in value and by 3,7% in volume
Russia pharma market growth in January-February 2019
Source: IQVIA databases. Retail, Public, DLO, RLO (excluding food supplements and diagnostic agents), TRD Prices
151816
114
129
12
M02/YTD’19
149
M02/YTD’18
179
149
+20%
Retail
Public (EXCL. DLO AND RLO)
Reimbursement
Regional Reimbursement
0.7 0.7
M02/YTD’19
0,1
M02/YTD’18
0,1
0,8 0,8
+3,7%
VALUE, BLN RUB VOLUME, BLN PACKS
+25%
+108%
+14%
+14%
+31%
+6,7%
+3,8%
-2,6%
2
Retail Sell-Out: Market grew by 4,7% in value and deceased by 4,1% in volume
Russia pharma market growth in January-February 2019
Source: Pharmatrend (excluding food supplements and diagnostic agents), FIN Prices
VALUE, BLN RUB
YoY growth, % YoY growth, %
VOLUME, BLN PACKS
53%
47%
M02/YTD’18
51%
M02/YTD’19
49%
147154
+4,7%
RXOTC
66%
M02/YTD’18
68%
32%
M02/YTD’19
34%
0,760,73
-4,1%
+0,6%
+9,2%
-7,1%
+2,2%
3
Volume, mln packs
Sell-In vs Sell-Out, OTC registered drugs
Source: Retail Audit and Pharmatrend. OTC registered drugs
190
240
200
150
270
160
280
170
230
180
210
300
220
250
290
260
2018/09
255
240244243
2018/02
292
283
227
2018/03
246
2018/04 2018/05
237
225
216
2018/06
238
222
207
208
2018/07
226
221
2018/08
243
2018/10
241
248242
238
2018/12
225
253
2018/11
254
246
2019/01 2019/02
Sell-In Sell-Out
Mln
pa
ck
s
4
TOP-15 corporations on Russian market, January-February 2019
2,5%
MENARINI
PFIZER
SERVIER
Total pharma market
TAKEDA
SANOFI-AVENTIS
TEVA
SANDOZ
BAYER HEALTHCARE
JOHNSON & JOHNSON
2,3%NOVARTIS
3,9%
OTCPHARM
KRKA
GLAXOSMITHKLINE 2,1%
GEDEON RICHTER
100,0%
4,8%
2,6%
2,5%
2,4%
2,2%
2,1%
2,0%
2,0%
1,9%
1,8%
ABBOTT
2,3%
27%
45%
20%
15%
11%
8%
-3%
14%
9%
13%
12%
29%
7%
10%
18%
6%
-6%
4%
6%
8%
-2%
-8%
-2%
-1%
-9%
8%
14%
1%
15%
2%
3%
7%
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Market share, M02/YTD’19In percent in Local Currency
15
Source: IQVIA databases. Retail, Public, DLO, RLO (excluding food supplements and diagnostic agents), TRD Prices
5
TOP-15 brands on Russian market, January-February 2019
ACTOVEGIN
REVLIMIDE
0,8%
SOLIRIS
XARELTO
NATRIUM CHLORIDUM
KAGOCEL
INGAVIRIN
0,5%
TOUJEO SOLOSTAR
OCTANATE
0,5%
ADVATE
ELAPRASE
Total pharma market
DETRALEX
MEXIDOL
MIRAMISTIN
KEYTRUDA
100,0%
0,7%
0,7%
0,7%
0,6%
0,5%
0,4%
0,4%
0,4%
0,4%
0,4%
0,4%
1,1%
2%
47%
20%
96%
70%
296%
14%
45%
94%
1 903%
1 770%
78%
12%
16%
4%
801%
305%
-4%
39%
101%
4%
14%
38%
88%
76%
1 511%
1 116%
1%
14%
0%
4%
1 181%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Source: IQVIA databases. Retail, Public, DLO, RLO (excluding food supplements and diagnostic agents), TRD Prices
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
6
Plans of purchases – new offering launched in Q2 2019
7
Manufacturer
DistributorProcurement
announce-
ment
Documents
Customers must publish Plans of purchases, positions which are not included into Plans can not be bought
Goods flow
Customer
(Ministry,
hospital
etc)
Patients
Hospital
Scheduled
plans of
Procurement
Publication
of the
Contract
TendersPlans of
Purchases
Tenders.
Contracts
New!
Modules, provided by IQVIA
Zakupki.gov.ru
8
Plans of purchases, relevant facts
Frequency DAP Granularity Panel/Universe Back Data
Weekly 2018www.zakupki.gov.ruNational
RegionalMunicipal
2 days
Methodology
Granularity
Delivery tools
Published Plans of Drug Procurement.
The data is based on information on published tenders at
www.zakupki.gov.ru
Without extrapolation. Volumes are in primary published units. Classification by
Customers, molecules and release forms.
National level + 83 regions + Account Level data
▪ Online IQVIA Tool
▪ Customized E-Mail newsletters
Key indicators
Market Definition
9
IQVIA is launching Plans of Purchases offering that could beapplied for immediate monitoring and medium-term planning
Rating of Federal Districts by bublished plans of
purchases for 2019, as per current version of plans
TOP5 molecules to be purchased in 2019 as per current
versions of plans
TOP5 molecules by volumes to be announced
in 2Q’19 as per current versions of plans
TOP5 EphMRA-2 categoris by volumes to be
announced in 2019 as per current versions of
plans
1 2
3 4
6,2
3,3
5,8
5,0
4,3
LOPINAVIR*RITONAVIR
LENALIDOMIDE
VACCINE, PNEUMOCOCCAL
ECULIZUMAB
RALTEGRAVIR
Bln
rub
3,1
1,6
2,2
1,61,4
LOPINAVIR*RITONAVIR
RALTEGRAVIR
RITUXIMAB
ECULIZUMAB
TERIFLUNOMIDE
61.8%7.2%
6.6%
7,5%
4,2%
5,1%2,5%
5,0%
Central
Volga
Northwestern
Far Eastern
Siberian
Southern
Ural
North Caucasus
Bln
rub
Bln
rub
10,0
48,2
24,0
11,68,9 L04 IMMUNOSUPPRESSIVE AGENTS
L01 ANTINEOPLASTICS
J05 ANTIVIRALS FOR SYSTEMIC USE
J07 VACCINES
B02 ANTIFIBRINOLYTICS, ANTIDOTES TO ANTI-COAGULANTS, INHIBITORS, BLOOD COAGULATION AND HAEMOSTYPTICSB
lnru
b
10
Advertisement cost, Growth Y-to-Y
TOP-10 products by growth in advertisement investments in January-February 2019
Total salesBln RUB
Sales, Growth Y-to-Y
1.000%
276%
1.000%
1.000%
1.000%
145%
117%
99%
83%
81%
SNUP
0,86
GRAMMIDIN
FESTAL
0,49
LONGIDAZA
DETRALEX
AQUADETRIM
DE NOL 0,35
BRONCHO MUNAL
ERGOFERON
MICROLAX 0,41
0,62
0,51
0,25
0,24
0,37
0,76
39%
31%
17%
30%
2%
14%
11%
0%
46%
18%
The rank in calculated among TOP-200 Brands by sales with advertising cost greater than 50 mln RUB
Source: IQVIA databases. Pharmatrend, Mediascope data, FIN Prices
11
TOP-10 products by decline in advertisement investments in January-February 2019
Total salesBln RUB
Sales, Growth Y-to-Y
-24%
-27%
-49%
-40%
-29%
-34%
-39%
-36%
-23%
-23%
0,23
1,17
0,31
0,74
DOCTOR MOM
NUROFEN
0,26HYLAK FORTE
PENTALGIN
NOVO PASSIT
COMPLIVIT
CODELAC
STREPSILS
PROSTAMOL UNO
DUSPATALIN
0,51
0,38
0,60
0,36
0,34
-7%
11%
-7%
-3%
11%
-15%
-23%
4%
0%
2%
Advertisement cost, Growth Y-to-Y
The rank in calculated among TOP-200 Brands by sales with advertising cost greater than 50 mln RUB
Source: IQVIA databases. Pharmatrend, Mediascope data, FIN Prices
12
Indicator KZT USD EUR PACKS
Value M02/YTD’19, Bln. 71 0,19 0,16 0,10
Growth M02/YTD’19% 8,5% -7,3% 0,3% -3,4%
Market grew by 8,5% in value and decreased by 3,4% in volume
Kazakhstan pharma market growth in January-February 2019
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
8
52
M02/YTD’18
44
11
11
71
11
M02/YTD’19
65
+8,5%
Retail
Hospital
Free & Co-Payment
M02/YTD’18
0,09
0,010,01
0,09
M02/YTD’19
0,10 0,10
-3,4%
VALUE, BLN KZT VOLUME, BLN PACKS
-0,8%
+18%
-20%
-8,5%
-0,4%
-26%
13
TOP-15 corporations on Kazakhstan market, January-February 2019
GEDEON RICHTER
NOBEL-AFF
2,5%
Total pharma market
SANOFI-AVENTIS
BAYER HEALTHCARE
TEVA
1,9%
2,5%
ABBOTT
TAKEDA
SANDOZ GROUP
GLAXOSMITHKLINE
3,6%
SERVIER
MENARINI
WORLD MEDICINE
ABDI IBR.GLOBAL PH
100,0%
6,9%
4,8%
4,0%
3,0%
2,9%
2,8%
2,2%
2,7%
2,6%
2,3%
2,2%
SANTO
JOHNSON & JOHNSON
-3%
3%
4%
25%
17%
9%
12%
-13%
-18%
34%
-8%
22%
8%
23%
17%
35%
-3%
12%
2%
-3%
-4%
19%
-13%
-20%
2%
2%
10%
-1%
-4%
-20%
16%
-15%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
14
TOP-15 brands on Kazakhstan market, January-February 2019
IMMUTIN
ACTOVEGIN
Total pharma market
AVASTIN
THERAFLU
VIFERON
CEFAZOLIN
CANEPHRON N
PHYSIOTENZ
0,6%
SPIRITUS AETHYLIC 0,6%
0,6%
1,1%
NIMESIL
0,5%
IMMUNATE
0,7%
HYLAK FORTE
CORONIM 10
100,0%
0,7%
0,6%
0,6%
0,5%
0,6%
0,5%
0,5%
0,5%
GORDOX
MUCALTIN
0,5%
6%
27%
9%
4%
-4%
54%
51%
16%
7%
16%
126%
16%
65%
30%
2%
-8%
-12%
-3%
51%
12%
-1%
18%
-1%
158%
-14%
8%
20%
-13%
-2%
13%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
15
Indicator BLR USD EUR PACKS
Value M02/YTD’19, Bln. 0,33 0,15 0,13 0,06
Growth M02/YTD’19% 8,0% -0,8% 6,8% 1,4%
Market grew by 8% in value and by 1,4% in volume
Belarus pharma market growth in January-February 2019
0,07
M02/YTD’18
0,24
0,06
M02/YTD’19
0,26
0,300,33
+8,0%
Retail
Hospital
0,01 0,01
0,05
M02/YTD’19M02/YTD’18
0,05
0,06 0,06
+1,4%
VALUE, BLN BLR VOLUME, BLN PACKS
+6,6%
+14%
+0,4%
+6,9%
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
16
TOP-15 corporations on Belarus market, January-February 2019
3,1%
3,8%
Total pharma market
SANOFI
BORISOV ZMP
BELMEDPREPARATY RUE
LEKPHARM JLLC
NOVARTIS
KRKA
PHARMLAND JV LTD
2,4%
PHARMTECHNOLOGY LTD
BAYER HEALTHCARE
MINSKINTERCAPS MRUE
GEDEON RICHTER
GSK
OLAINFARM AS
100,0%
7,6%
7,5%
5,3%
4,0%
3,7%
3,1%
2,6%
2,5%
2,0%
1,9%
1,9%
1,6%
BERLIN-CH/MENARINI
TAKEDA
30%
7%
-26%
8%
-9%
15%
67%
4%
18%
14%
30%
22%
-2%
-4%
14%
19%
-6%
-2%
27%
37%
1%
-4%
12%
12%
2%
4%
11%
6%
-6%
-1%
12%
-21%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
17
TOP-15 brands on Belarus market, January-February 2019
0,8%
Total pharma market
IMOVAX POLIO
DACLASOFT 0,7%
CEREPRO
METFORMIN
T-MAB
GLICLAZIDE MR
0,5%
1,0%
LISINOPRIL
ATORVASTATIN
BERIATE
0,5%
ACTOVEGIN
LOSARTAN
GROPRINOSIN
100,0%
1,0%
0,7%
0,7%
0,6%
0,5%
0,6%
0,5%
0,5%
0,5%
0,5%
SODIUM CHLORIDE
XARELTO
FLUSTOP
23%
119%
2 856%
302%
8%
9%
10 499%
57%
9%
4%
301%
29%
13%
7%
13%
308%
1%
53%
301%
8%
2 736%
7%
2 484%
5%
-4%
125%
9%
34%
13%
16%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Source: IQVIA databases. Retail, Hospital (excluding food supplements and diagnostic agents), TRD Prices
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
18
Indicator AMD USD EUR PACKS
Value M02/YTD’19, Bln. 13,2 0,03 0,02 0,01
Growth M02/YTD’19% 5,2% 4,2% 12% 0,7%
Market grew by 5,2% in value and by 0,7% in volume
Armenia pharma market growth in January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
M02/YTD’18 M02/YTD’19
13,212,5
+5,2%
Retail
M02/YTD’18 M02/YTD’19
0,01 0,01
+0,7%
VALUE, BLN AMD VOLUME, BLN PACKS
19
TOP-15 corporations on Armenia market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
2,0%
Total pharma market
BERLIN-CH/MENARINI
SERVIER
100,0%
NOVARTIS
GSK
KRKA
SANOFI
TAKEDA
GEDEON RICHTER
EGIS
DENK PHARMA
BAYER HEALTHCARE 2,4%
ABBOTT
GL CORPORATION
6,4%
5,7%
4,3%
3,8%
3,0%
3,7%
3,3%
3,1%
3,0%
1,8%
2,7%
2,2%
2,0%ASTELLAS PHARMA
STADA
5%
27%
6%
-1%
7%
-3%
-6%
3%
-6%
4%
-3%
-5%
13%
12%
-14%
-14%
1%
-4%
13%
-2%
1%
-1%
-4%
-10%
-3%
0%
-9%
-8%
6%
11%
-16%
-17%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
20
TOP-15 brands on Armenia market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
Total pharma market
PRESTANCE
CARDIOMAGNYL
CONCOR
ACTOVEGIN
DUPHASTON
0,4%
CEFTRIAXONE-ASTERIA
NIMESIL
0,7%
LENDACIN
0,6%
THERAFLU
SODIUM CHLORIDE
1,0%
0,5%
VITAMIN D3
DEXALGIN SACHET
100,0%
0,9%
0,8%
0,7%
0,6%
0,5%
0,5%
0,5%
0,4%
0,5%
0,4%
XARELTO
TRIPLIXAM
OTRIVIN
5%
1%
21%
16%
4%
-17%
-15%
7%
-22%
-18%
-14%
0%
57%
56%
0%
19%
-12%
1%
23%
-25%
16%
12%
-8%
1%
-24%
-21%
-14%
1%
-2%
49%
34%
11%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
21
Indicator GEL USD EUR PACKS
Value M02/YTD’19, Bln. 0,11 0,04 0,04 0,02
Growth M02/YTD’19% 7,8% 1,5% 10% 10%
Market grew by 7,8% in value and by 10% in volume
Georgia pharma market growth in January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
M02/YTD’19M02/YTD’18
0,100,11
+7,8%
Retail
M02/YTD’18
0,02
M02/YTD’19
0,02
+10%
VALUE, BLN GEL VOLUME, BLN PACKS
22
TOP-15 corporations on Georgia market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
G.M.P. LTD
1,5%
Total pharma market
1,6%
BERLIN-CH/MENARINI
4,4%
WORLD MEDICINE
AVERSI-RATIONAL LTD
GSK
3,1%
SANOFI
SERVIER
KRKA
BAYER HEALTHCARE
NOVARTIS
5,5%
ASTRAZENECA
ROCHE
TAKEDA
EGIS
GEDEON RICHTER
100,0%
5,4%
4,5%
3,8%
2,3%
2,9%
3,6%
1,7%
3,5%
2,1%
1,5%
-23%
8%
22%
13%
10%
38%
1%
-8%
-11%
6%
15%
5%
-3%
7%
13%
1%
4%
37%
9%
10%
3%
11%
-3%
-10%
-1%
3%
9%
17%
0%
6%
11%
-5%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
23
TOP-15 brands on Georgia market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
0,6%
0,7%
XARELTO
Total pharma market
CARDIOMAGNYL
NIMESIL
0,5%
TRIPLIXAM
NO-SPA
PRESTANCE
0,4%
SODIUM CHLORIDE 0,6%
THERAFLU
AUGMENTIN
CORSIZ
CEFAMED
PULMICORT
FRAXIPARINE
CLEXANE
0,4%
100,0%
1,0%
0,8%
0,7%
0,7%
0,5%
0,7%
0,4%
0,4%
0,7%
DETRALEX
34%
8%
-12%
0%
23%
-4%
-9%
12%
6%
37%
194%
6%
92%
-18%
3%
27%
-9%
4%
37%
10%
10%
-1%
19%
34%
28%
15%
199%
5%
57%
-10%
-1%
3%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
24
Indicator AZN USD EUR PACKS
Value M02/YTD’19, Bln. 0,12 0,07 0,06 0,04
Growth M02/YTD’19, % 12% 12% 21% 5,2%
Market grew by 12% in value and by 5,2% in volume
Azerbaijan pharma market growth in January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
M02/YTD’18 M02/YTD’19
0,120,11
+12%
Retail
0,04
M02/YTD’18 M02/YTD’19
0,04
+5,2%
VALUE, BLN AZN VOLUME, BLN PACKS
25
TOP-15 corporations on Azerbaijan market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
2,9%
KRKA
BERLIN-CH/MENARINI
Total pharma market
NOVATOR PHARMA
GSK
NOVARTIS
1,3%
STADA
TAKEDA
SERVIER
NOBEL ILAC SANAYII
BORISOV ZMP
VEFA ILAC SANAYI
1,8%
EGIS
HERBA FLORA
MARATHON PHARMA
100,0%
2,2%
3,7%
3,4%
2,8%
2,4%
1,9%
1,8%
1,6%
1,6%
1,3%
1,2%
SANOFI
1,7%
0%
12%
39%
5%
0%
19%
-5%
-4%
-2%
9%
13%
43%
3%
22%
11%
-17%
-19%
41%
-2%
2%
5%
-15%
-6%
-1%
11%
17%
-1%
21%
5%
14%
2%
-18%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
26
TOP-15 brands on Azerbaijan market, January-February 2019
Source: IQVIA databases. Retail Market (exclude food supplements and diagnostic agents), TRD Prices
NIMESIL
ACTOVEGIN
SODIUM CHLORIDE
0,6%
SPASMALGON
NUROFEN FOR CHILD
AUGMENTIN
ETHANOL 0,6%
CLEXANE
RINGER`S SOLUTION
CEFTRIAXONE-AKOS
0,6%
TYLOL HOT
0,5%
CARDIOMAGNYL
0,8%
TRIPLIXAM
ALBUNORM
100,0%
1,3%
0,5%
0,6%
0,8%
0,7%
0,7%
0,5%
0,5%
0,4%
0,4%
Total pharma market
TRIOCEF
0%
6%
12%
-6%
59%
104%
11%
35%
-12%
68%
26%
-26%
9%
43%
955%
26%
-5%
7%
59%
5%
33%
-16%
-6%
7%
26%
71%
75%
26%
-26%
6%
54%
575%
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Value growth / declineIn percent in Local Currency
Volume growth / declineIn percent in Packs
Market share, M02/YTD’19In percent in Local Currency
27
Please Contact Us for More Information
Svetlana Nikulina
Sales Director
+7 499 272 05 00
Anton Kalyapin
Associate Director, Offering
+7 499 272 05 00
Nadezhda Kalinich
Client Service Representative
+7 499 272 05 00